Benzinga | Nov 4, 2020 04:01PM EST

Axonics Modulation Tech Q3 EPS $(0.24) Beats $(0.50) Estimate, Sales $35.20M Beat $22.95M Estimate

Axonics Modulation Tech (NASDAQ:AXNX) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.50) by 52 percent. This is a 73.03 percent increase over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $35.20 million which beat the analyst consensus estimate of $22.95 million by 53.38 percent. This is a 2.59K percent increase over sales of $1.31 million the same period last year.